Maple Grove, MN · Founded 2007 · Privately Held (backing)
Developer of an artificial chordae delivery system designed to resolve and restore normal mitral valve function. NeoChord is based in Maple Grove, MN and was founded in 2007. Its last reported valuation was $50 million in Jun 2015. It has raised $95.4 million across 13 recorded rounds; the latest was a $493,240 seed round in Feb 2025.
Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$95.4M
Last round
Seed Round
Feb 2025
Team — not yet on record
No current team members for NeoChord are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeoChord with a free account
·The complete investor list: 18 names
·Watch NeoChord: the Monday email on marks, rounds and moves
